Inventor profile of:

Marc Stefan Robillard

City:

Eindhoven

Country:

Netherlands

Published Applications:

27

Last publication date:

2025-04-10

Top Assignees for applications by Marc Stefan Robillard

The entities that hold a legal rights for patent applications filed by inventor Robillard Marc Stefan:

Recent patent applications by Robillard Marc Stefan

Marc Stefan Robillard from Eindhoven, NL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-10
US20250114489A1
Human necessities

MASKED IL12 PROTEIN

#2 | 2022-11-10
US20220356169A1
Chemistry; metallurgy

TETRAZINES FOR HIGH CLICK RELEASE SPEED AND YIELD

#3 | 2022-10-20
US20220331458A1
Human necessities

AGENTS FOR CLEAVING LABELS FROM BIOMOLECULES IN VIVO

#4 | 2021-09-30
US20210299286A1
Human necessities

TETRAZINES FOR HIGH CLICK CONJUGATION YIELD IN VIVO AND HIGH CLICK RELEASE YIELD

#5 | 2021-06-03
US20210162060A1
Human necessities

Bio-orthogonal drug activation

#6 | 2021-01-07
US20210002320A1
Chemistry; metallurgy

CHEMICALLY CLEAVABLE GROUP

#7 | 2019-11-07
US20190336612A1
Human necessities

Bio-orthogonal drug activation

#8 | 2019-08-15
US20190247513A1
Human necessities

Cleavable tetrazine used in bio-orthogonal drug activation

#9 | 2017-05-25
US20170143840A1
Human necessities

Bio-orthogonal drug activation

#10 | 2016-06-02
US20160151505A1
Human necessities

BIO-ORTHOGONAL DRUG ACTIVATION

#11 | 2016-04-21
US20160106859A1
Human necessities

Bio-orthogonal drug activation

#12 | 2015-12-03
US20150344514A1
Chemistry; metallurgy

Chemically cleavable group

#13 | 2015-10-22
US20150297741A1
Human necessities

BIO-ORTHOGONAL DRUG ACTIVATION

#14 | 2015-05-28
US20150147273A1
Human necessities

RADIOLABELED ANALOG(S) OF COMPOUND 0118 AND USE THEREOF IN CONNECTION WITH PET AND/OR SPECT IMAGING TO DETERMINE WHETHER A PHARMACEUTICAL CONTAINING COMPOUND 0118 IS A CANDIDATE CANCER TREATMENT FOR A PATIENT

#15 | 2014-07-17
US20140199331A1
Human necessities

Bio-orthogonal drug activation

#16 | 2014-04-03
US20140093522A1
Human necessities

Bio-orthogonal drug activation

#17 | 2014-04-03
US20140093450A1
Human necessities

Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene

#18 | 2013-10-17
US20130272959A1
Human necessities

Agents for clearing biomolecules from circulation

#19 | 2013-07-25
US20130189184A1
Human necessities

Pretargeting kit, method and agents used therein

#20 | 2012-02-16
US20120039803A1
Human necessities

PRETARGETING KIT, METHOD AND AGENTS USED THEREIN

#21 | 2012-02-09
US20120034161A1
Human necessities

PRETARGETING KIT, METHOD AND AGENTS USED THEREIN

#22 | 2011-03-17
US20110064667A1
Chemistry; metallurgy

Azide modified charge sensitive channel proteins

#23 | 2010-09-09
US20100227798A1
Human necessities

USE OF THE STAUDINGER LIGATION IN IN VIVO ASSEMBLY OF A BIOLOGICALLY ACTIVE COMPOUND

#24 | 2008-11-06
US20080274057A1
Human necessities

Staudinger Reaction in Imaging and Therapy and Kits for Use in Imaging and Therapy

#25 | 2008-10-30
US20080267878A1
Human necessities

Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne Cycloaddition

#26 | 2008-07-31
US20080181847A1
Human necessities

Targeted Imaging and/or Therapy Using the Staudinger Ligation

#27 | 2008-03-27
US20080075661A1
Human necessities

Compounds, Kits and Methods for Use in Medical Imaging

InventorID:

353469 ⎘